Evidence map›Paper›PMID 26032210›Full record

ArticleJournal of musculoskeletal & neuronal interactions2015

The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.

P H Rauma, J A Pasco, M Berk, A L Stuart, H Koivumaa-Honkanen, R J Honkanen, J M Hodge, L J Williams

Open access · greenAbstract read
In one paragraph

Article in Journal of musculoskeletal & neuronal interactions, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Bone Metabolism in Patients Treated for Depression.International journal of environmental research and public health · 2020
    Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

P H RaumaSocial Pharmacy, School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland (UEF), Kuopio, Finland.
J A PascoSchool of Medicine, Deakin University, Geelong, Australia.
M BerkSchool of Medicine, Deakin University, Geelong, Australia.
A L StuartSchool of Medicine, Deakin University, Geelong, Australia.
H Koivumaa-HonkanenInstitute of Clinical Medicine, Psychiatry, UEF, Kuopio, Finland.
R J HonkanenBone and Cartilage Research Unit, Surgery, Institute of Clinical Medicine, UEF, Kuopio, Finland.
J M HodgeSchool of Medicine, Deakin University, Geelong, Australia.
L J WilliamsSchool of Medicine, Deakin University, Geelong, Australia.
Deakin University · AUUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveBoth depression and use of antidepressants have been negatively associated with bone mineral density (BMD) but mainly in studies among postmenopausal women. Therefore, the aim of this study was to investigate these relationships in men.

methodsBetween 2006 and 2011, 928 men (aged 24-98 years) from the Geelong Osteoporosis Study completed a comprehensive questionnaire, clinical measurements and had BMD assessments at the forearm, spine, total hip and total body. Major depressive disorder (MDD) was identified using a structured clinical interview (SCID-I/NP). The cross-sectional associations between BMD and both MDD and antidepressant use were analyzed using multivariable linear regression.

resultsOf the study population, 84 (9.1%) men had a single MDD episode, 50 (5.4%) had recurrent episodes and 65 (7.0%) were using antidepressants at the time of assessment. Following adjustments, recurrent MDD was associated with lower BMD at the forearm and total body (-6.5%, P=0.033 and -2.5%, P=0.033, respectively compared to men with no history of MDD), while single MDD episodes were associated with higher BMD at the total hip (+3.4%, P=0.030). Antidepressant use was associated with lower BMD only in lower-weight men (<75-110 kg depending on bone site).

conclusionsBoth depression and use of antidepressants should be taken into account as possible risk factors for osteoporosis in men.

Indexed as

AdultAgedAntidepressive AgentsBody WeightBone DensityCross-Sectional StudiesForearmHumansMajor Depressive DisorderMaleMiddle AgedOsteoporosisRecurrenceRisk FactorsSelective Serotonin Reuptake InhibitorsAntidepressive AgentsSelective Serotonin Reuptake Inhibitors

Identifiers

PMID26032210
PMCPMC5133721
OpenAlexW836544229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.